Gregory Maniatis, MD
Interventional Cardiology · Staten Island, NYNPI 1932499290
Payments from drug & device makers
Across 112 payments — averaging $70.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abbott$2K
- Edwards Lifesciences$1K
- Philips North America LLC$838
- Boston Scientific$700
- Spectrawave, Inc$320
- plus $466 from 6 others
What the payments were for
- Food & beverage$7,932100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 39 | $2,643 |
| Abbott | 28 | $1,748 |
| Edwards Lifesciences | 18 | $1,217 |
| Philips North America LLC | 11 | $838 |
| Boston Scientific | 5 | $700 |
| Spectrawave, Inc | 2 | $320 |
| Teleflex LLC | 1 | $143 |
| Terumo Medical Corporation | 1 | $131 |
| Abiomed | 3 | $88 |
| Shockwave Medical, Inc | 2 | $73 |
| Heartflow, Inc. | 1 | $20 |
| AbbVie | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$1,243
- SAPIEN 3 Ultra RESILIA$470
- MitraClip$421
- CoreValve Evolut$361
- HyperVue Imaging System$320
- Starlight Imaging Catheter$320
- DRAGONFLY OPSTAR$285
- SYNERGY$276
- (6575) Coronary Undivided$275
- INSPIRIS RESILIA aortic valve$253
- (BQ9) Coronary IVUS$230
- MANTA$143
- MetaCross$131
- Glidesheath$131
- AMPLATZER$128
- CLARIA MRI QUAD CRT-D SURESCAN$127
- Resolute$127
- OPTIS$126
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$111
- Dragonfly OCT$104
How this compares
$7,932 in reported general payments places this provider in the 40th percentile of 382 interventional cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 89 | $90,723 |
| EntrestoSacubitril/Valsartan | 23 | $30,647 |
| Metoprolol Succinate | 124 | $1,739 |
| Atorvastatin Calcium | 119 | $1,224 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 17 | $782 |
| Amlodipine Besylate | 55 | $426 |
| Losartan Potassium | 34 | $343 |
| Torsemide | 15 | $263 |
| Rosuvastatin Calcium | 26 | $260 |
| Furosemide | 48 | $203 |
| Pravastatin Sodium | 16 | $198 |
| ClopidogrelClopidogrel Bisulfate | 17 | $191 |
| Valsartan | 12 | $189 |
| Amiodarone Hcl | 12 | $171 |
| Hydrochlorothiazide | 21 | $127 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Staten Island
- Martin LeonNew York$13.5M
- David CohenRoslyn$9.8M
- Susheel KodaliNew York$6M
- Mohamed Azeem LatibBronx$4.6M
- Richard ShlofmitzRoslyn$4.5M
- Deepak BhattNew York$4.1M
- Samin SharmaNew York$3.7M
- Annapoorna KiniNew York$3.5M
- Sahil ParikhNew York$2.7M
- George DangasNew York$2.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.